Երկիր: Կանադա
Լեզու: անգլերեն
Աղբյուրը: Health Canada
TOLTERODINE TARTRATE
RANBAXY PHARMACEUTICALS CANADA INC.
G04BD07
TOLTERODINE
1MG
TABLET
TOLTERODINE TARTRATE 1MG
ORAL
100
Prescription
Antimuscarinics
Active ingredient group (AIG) number: 0135202001; AHFS:
APPROVED
2015-12-16
_Pr_ _RAN_ _™_ _-TOLTERODINE (tolterodine L-tartrate) Tablets Product Monograph _ _Page 1 of 30_ PRODUCT MONOGRAPH PR RAN ™ -TOLTERODINE (TOLTERODINE L-TARTRATE) 1 MG AND 2 MG TABLETS ANTICHOLINERGIC - ANTISPASMODIC AGENT RANBAXY PHARMACEUTICALS CANADA INC. 2680 MATHESON BLVD. E., SUITE 200 MISSISSAUGA, ONTARIO L4W 0A5 DATE OF PREPARATION: MAY 27, 2015 CONTROL NO: 169804, 184483 RAN trademark owned by Sun Pharmaceutical Industries Ltd. _Pr_ _RAN_ _™_ _-TOLTERODINE (tolterodine L-tartrate) Tablets Product Monograph _ _Page 2 of 30_ TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ............................................................. 3 SUMMARY PRODUCT INFORMATION .................................................................................. 3 INDICATIONS AND CLINICAL USE ....................................................................................... 3 CONTRAINDICATIONS ............................................................................................................. 3 WARNINGS AND PRECAUTIONS ........................................................................................... 4 ADVERSE REACTIONS ............................................................................................................. 6 DRUG INTERACTIONS.............................................................................................................. 8 DOSAGE AND ADMINISTRATION ......................................................................................... 9 OVERDOSAGE .......................................................................................................................... 10 ACTION AND CLINICAL PHARMACOLOGY ...................................................................... 11 STORAGE AND STABILITY ................................................................................................... 13 SPECIAL HANDLING INSTRUCTIONS ................................................................................. 13 DOSAGE FORMS, COMPOSITION AND PACKAGING Կարդացեք ամբողջական փաստաթուղթը